Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313213249> ?p ?o ?g. }
- W4313213249 endingPage "7576" @default.
- W4313213249 startingPage "7565" @default.
- W4313213249 abstract "Monitoring HIV-1 drug resistance mutations (DRM) in treated patients on combination antiretroviral therapy (cART) with a detectable HIV-1 viral load (VL) is important for the selection of appropriate cART. Currently, there is limited data on HIV DRM at low-level viremia (LLV) (VL 401-999 copies/mL) due to the use of a threshold of VL ≥1000 copies/mL for HIV DRM testing. We here assess the performance of an in-house HIV drug resistance genotyping assay using plasma for the detection of DRM at LLV.We used a total of 96 HIV plasma samples from the population-based Botswana Combination Prevention Project (BCPP). The samples were stratified by VL groups: 50 samples had LLV, defined as 401-999 copies/mL, and 46 had ≥1000 copies/mL. HIV pol (PR and RT) region was amplified and sequenced using an in-house genotyping assay with BigDye sequencing chemistry. Known HIV DRMs were identified using the Stanford HIV Drug Resistance Database. Genotyping success rate between the two groups was estimated and compared using the comparison of proportions test.The overall genotyping success rate was 79% (76/96). For VL groups, the genotyping success was 72% (36/50) at LLV and 87% (40/46) at VL ≥1000 copies/mL. Among generated sequences, the overall prevalence of individuals with at least 1 major or intermediate-associated DRM was 24% (18/76). The proportions of NNRTI-, NRTI- and PI-associated resistance mutations were 28%, 24%, and 0%, respectively. The most predominant mutations detected were K103N (18%) and M184V (12%) in NNRTI- and NRTI-associated mutations, respectively. The prevalence of DRM was 17% (6/36) at LLV and 30% (12/40) at VL ≥1000 copies/mL.The in-house HIV genotyping assay successfully genotyped 72% of LLV samples and was able to detect 17% of DRM amongst them. Our results highlight the possibility and clinical significance of genotyping HIV among individuals with LLV." @default.
- W4313213249 created "2023-01-06" @default.
- W4313213249 creator A5003674936 @default.
- W4313213249 creator A5010657706 @default.
- W4313213249 creator A5012678394 @default.
- W4313213249 creator A5019435296 @default.
- W4313213249 creator A5021258464 @default.
- W4313213249 creator A5030501259 @default.
- W4313213249 creator A5038310557 @default.
- W4313213249 creator A5040388137 @default.
- W4313213249 creator A5043441542 @default.
- W4313213249 creator A5044455382 @default.
- W4313213249 creator A5047050318 @default.
- W4313213249 creator A5055839016 @default.
- W4313213249 creator A5057590991 @default.
- W4313213249 creator A5067331905 @default.
- W4313213249 creator A5075269031 @default.
- W4313213249 creator A5075680133 @default.
- W4313213249 creator A5080092053 @default.
- W4313213249 creator A5081093020 @default.
- W4313213249 creator A5089544605 @default.
- W4313213249 date "2022-12-01" @default.
- W4313213249 modified "2023-10-13" @default.
- W4313213249 title "HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads" @default.
- W4313213249 cites W167285274 @default.
- W4313213249 cites W179295540 @default.
- W4313213249 cites W1986078704 @default.
- W4313213249 cites W1996459980 @default.
- W4313213249 cites W2000114733 @default.
- W4313213249 cites W2032127445 @default.
- W4313213249 cites W2043256741 @default.
- W4313213249 cites W2044514751 @default.
- W4313213249 cites W2072569609 @default.
- W4313213249 cites W2084784401 @default.
- W4313213249 cites W2093920807 @default.
- W4313213249 cites W2126249455 @default.
- W4313213249 cites W2127256232 @default.
- W4313213249 cites W2133758885 @default.
- W4313213249 cites W2139069242 @default.
- W4313213249 cites W2142639094 @default.
- W4313213249 cites W2144716168 @default.
- W4313213249 cites W2145449008 @default.
- W4313213249 cites W2150215096 @default.
- W4313213249 cites W2155695907 @default.
- W4313213249 cites W216481071 @default.
- W4313213249 cites W2165433679 @default.
- W4313213249 cites W2184746840 @default.
- W4313213249 cites W2185884624 @default.
- W4313213249 cites W2289949354 @default.
- W4313213249 cites W2310218779 @default.
- W4313213249 cites W2332872599 @default.
- W4313213249 cites W2810129057 @default.
- W4313213249 cites W2884986477 @default.
- W4313213249 cites W2916132975 @default.
- W4313213249 cites W2958867317 @default.
- W4313213249 cites W2963164305 @default.
- W4313213249 cites W3042709814 @default.
- W4313213249 cites W3092285721 @default.
- W4313213249 cites W3118661271 @default.
- W4313213249 cites W3132866764 @default.
- W4313213249 cites W3186058944 @default.
- W4313213249 cites W4207048504 @default.
- W4313213249 cites W4213087840 @default.
- W4313213249 cites W4297914773 @default.
- W4313213249 doi "https://doi.org/10.2147/idr.s388816" @default.
- W4313213249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36582452" @default.
- W4313213249 hasPublicationYear "2022" @default.
- W4313213249 type Work @default.
- W4313213249 citedByCount "1" @default.
- W4313213249 countsByYear W43132132492023 @default.
- W4313213249 crossrefType "journal-article" @default.
- W4313213249 hasAuthorship W4313213249A5003674936 @default.
- W4313213249 hasAuthorship W4313213249A5010657706 @default.
- W4313213249 hasAuthorship W4313213249A5012678394 @default.
- W4313213249 hasAuthorship W4313213249A5019435296 @default.
- W4313213249 hasAuthorship W4313213249A5021258464 @default.
- W4313213249 hasAuthorship W4313213249A5030501259 @default.
- W4313213249 hasAuthorship W4313213249A5038310557 @default.
- W4313213249 hasAuthorship W4313213249A5040388137 @default.
- W4313213249 hasAuthorship W4313213249A5043441542 @default.
- W4313213249 hasAuthorship W4313213249A5044455382 @default.
- W4313213249 hasAuthorship W4313213249A5047050318 @default.
- W4313213249 hasAuthorship W4313213249A5055839016 @default.
- W4313213249 hasAuthorship W4313213249A5057590991 @default.
- W4313213249 hasAuthorship W4313213249A5067331905 @default.
- W4313213249 hasAuthorship W4313213249A5075269031 @default.
- W4313213249 hasAuthorship W4313213249A5075680133 @default.
- W4313213249 hasAuthorship W4313213249A5080092053 @default.
- W4313213249 hasAuthorship W4313213249A5081093020 @default.
- W4313213249 hasAuthorship W4313213249A5089544605 @default.
- W4313213249 hasBestOaLocation W43132132491 @default.
- W4313213249 hasConcept C104317684 @default.
- W4313213249 hasConcept C114851261 @default.
- W4313213249 hasConcept C135763542 @default.
- W4313213249 hasConcept C142462285 @default.
- W4313213249 hasConcept C156719811 @default.
- W4313213249 hasConcept C159047783 @default.
- W4313213249 hasConcept C182707283 @default.